FKBP12.6 deficiency and defective calcium release channel (ryanodine receptor) function linked to exercise-induced sudden cardiac death

Cell

Volumn 113, Issue 7, 2003, Pages 829-840

  Wehrens, Xander H T ^a   Lehnart, Stephan E ^a   Huang, Fannie ^a   Vest, John A ^a   Reiken, Steven R ^a   Mohler, Peter J ^b   Sun, Jie ^a   Guatimosim, Silvia ^c   Song, Long Sheng ^c   Rosemblit, Nora ^a   D'Armiento, Jeanine M ^a   Napolitano, Carlo ^d   Memmi, Mirella ^d   Priori, Silvia G ^d   Lederer, W J ^c   Marks, Andrew R ^a  

^a New York Presbyterian Columbia University Medical Center   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF PAVIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; BETA ADRENERGIC RECEPTOR; CALCIUM ION; CYCLIC AMP DEPENDENT PROTEIN KINASE; FK 506 BINDING PROTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN; RYANODINE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM CONDUCTANCE; CALCIUM TRANSPORT; CARDIOMYOPATHY; CATECHOLAMINERGIC SYSTEM; CONTROLLED STUDY; EXERCISE TEST; FEMALE; GENE MUTATION; HEART CYCLE; HEART DEATH; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEART PROTECTION; HEART VENTRICLE TACHYCARDIA; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEPLETION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; RECEPTOR AFFINITY; RECEPTOR GENE; SARCOPLASMIC RETICULUM;

ANIMALIA;

EID: 0037708928     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(03)00434-3     Document Type: Article

References (29)

1. Bennett J.A., Clancy Y.C., McNeish J.D. Identification and characterization of the murine FK506 binding protein (FKBP) 12.6 gene. Mamm. Genome. 9:1998;1069-1071.
2. Brillantes A.B., Ondrias K., Scott A., Kobrinsky E., Ondriasova E., Moschella M.C., Jayaraman T., Landers M., Ehrlich B.E., Marks A.R. Stabilization of calcium release channel (ryanodine receptor) function by FK506-binding protein. Cell. 77:1994;513-523.
3. Fabiato A. Calcium-induced release of calcium from the cardiac sarcoplasmic reticulum. Am. J. Physiol. 245:1983;C1-C14.
4. Fisher J.D., Krikler D., Hallidie-Smith K.A. Familial polymorphic ventricular arrhythmias. a quarter century of successful medical treatment based on serial exercise-pharmacologic testing J. Am. Coll. Cardiol. 34:1999;2015-2022.
5. Fozzard H.A. Afterdepolarizations and triggered activity. Basic Res. Cardiol. 87:1992;105-113.
6. Gaburjakova M., Gaburjakova J., Reiken S., Huang F., Marx S.O., Rosemblit N., Marks A.R. FKBP12 binding modulates ryanodine receptor channel gating. J. Biol. Chem. 276:2001;16931-16935.
7. Huse M., Chen Y.G., Massague J., Kuriyan J. Crystal structure of the cytoplasmic domain of the type I TGF beta receptor in complex with FKBP12. Cell. 96:1999;425-436.
8. Jayaraman T., Brillantes A.-M.B., Timerman A.P., Erdjument-Bromage H., Fleischer S., Tempst P., Marks A.R. FK506 binding protein associated with the calcium release channel (ryanodine receptor). J. Biol. Chem. 267:1992;9474-9477.
9. Jiang D., Xiao B., Zhang L., Chen S.R. Enhanced basal activity of a cardiac Ca2+ release channel (ryanodine receptor) mutant associated with ventricular tachycardia and sudden death. Circ. Res. 91:2002;218-225.
10. (2+)-release channels from cardiac muscle. Circ. Res. 78:1996;990-997.
11. Laitinen P.J., Brown K.M., Piippo K., Swan H., Devaney J.M., Brahmbhatt B., Donarum E.A., Marino M., Tiso N., Viitasalo M.et al. Mutations of the cardiac ryanodine receptor (RyR2) gene in familial polymorphic ventricular tachycardia. Circulation. 103:2001;485-490.
12. Leenhardt A., Lucet V., Denjoy I., Grau F., Ngoc D.D., Coumel P. Catecholaminergic polymorphic ventricular tachycardia in children. A 7-year follow-up of 21 patients. Circulation. 91:1995;1512-1519.
13. Marban E., Robinson S.W., Wier W.G. Mechanisms of arrhythmogenic delayed and early afterdepolarizations in ferret ventricular muscle. J. Clin. Invest. 78:1986;1185-1192.
14. Marks A.R. Cardiac intracellular calcium release channels. role in heart failure Circ. Res. 87:2000;8-11.
15. Marx S.O., Reiken S., Hisamatsu Y., Jayaraman T., Burkhoff D., Rosemblit N., Marks A.R. PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor). defective regulation in failing hearts Cell. 101:2000;365-376.
16. Marx S.O., Reiken S., Hisamatsu Y., Gaburjakova M., Gaburjakova J., Yang Y.M., Rosemblit N., Marks A.R. Phosphorylation-dependent regulation of ryanodine receptors. A novel role for leucine/isoleucine zippers. J. Cell Biol. 153:2001;699-708.
17. Mitchell G.F., Jeron A., Koren G. Measurement of heart rate and Q-T interval in the conscious mouse. Am. J. Physiol. 274:1998;H747-H751.
18. Mohler P.J., Schott J.J., Gramolini A.O., Dilly K.W., Guatimosim S., duBell W.H., Song L.S., Haurogne K., Kyndt F., Ali M.E.et al. Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death. Nature. 421:2003;634-639.
19. Nabauer M., Callewart G., Cleeman L., Morad M. Regulation of calcium release is gated by calcium current, not gating charge, in cardiac myocytes. Science. 244:1989;800-803.
20. Pogwizd S.M., McKenzie J.P., Cain M.E. Mechanisms underlying spontaneous and induced ventricular arrhythmias in patients with idiopathic dilated cardiomyopathy. Circulation. 98:1998;2404-2414.
21. Pogwizd S.M., Schlotthauer K., Li L., Yuan W., Bers D.M. Arrhythmogenesis and contractile dysfunction in heart failure. Roles of sodium-calcium exchange, inward rectifier potassium current, and residual beta-adrenergic responsiveness Circ. Res. 88:2001;1159-1167.
22. Priori S.G., Napolitano C., Tiso N., Memmi M., Vignati G., Bloise R., Sorrentino V.V., Danieli G.A. Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia. Circulation. 103:2001;196-200.
23. Priori S.G., Napolitano C., Memmi M., Colombi B., Drago F., Gasparini M., DeSimone L., Coltorti F., Bloise R., Keegan R.et al. Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia. Circulation. 106:2002;69-74.
24. Reiken S., Gaburjakova M., Guatimosim S., Gomez A.M., D'Armiento J., Burkhoff D., Wang J., Vassort G., Lederer W.J., Marks A.R. Protein kinase A phosphorylation of the cardiac calcium release channel (ryanodine receptor) in normal and failing hearts. Role of phosphatases and response to isoproterenol. J. Biol. Chem. 278:2003;444-453.
25. Song Y., Belardinelli L. ATP promotes development of afterdepolarizations and triggered activity in cardiac myocytes. Am. J. Physiol. 267:1994;H2005-H2011.
26. Swan H., Piippo K., Viitasalo M., Heikkila P., Paavonen T., Kainulainen K., Kere J., Keto P., Kontula K., Toivonen L. Arrhythmic disorder mapped to chromosome 1q42-q43 causes malignant polymorphic ventricular tachycardia in structurally normal hearts. J. Am. Coll. Cardiol. 34:1999;2035-2042.
27. Valdivia H.H., Kaplan J.H., Ellis-Davies G.C., Lederer W.J. Rapid adaptation of cardiac ryanodine receptors. modulation by Mg2+ and phosphorylation Science. 267:1995;1997-2000.
28. Wit A.L., Rosen M.R. Pathophysiologic mechanisms of cardiac arrhythmias. Am. Heart J. 106:1983;798-811.
29. Xin H.B., Senbonmatsu T., Cheng D.S., Wang Y.X., Copello J.A., Ji G.J., Collier M.L., Deng K.Y., Jeyakumar L.H., Magnuson M.A.et al. Oestrogen protects FKBP12.6 null mice from cardiac hypertrophy. Nature. 416:2002;334-338.